Form C - Offering Statement:
SEC Accession No. 0001669191-20-000843
Filing Date
2020-12-18
Accepted
2020-12-18 16:55:24
Documents
9

Document Format Files

Seq Description Document Type Size
1 primary_doc.html C  
1 primary_doc.xml C 10696
2 OFFERING STATEMENT PDF offeringstatement.pdf EX-99 178814
3 OFFERING PAGE JPG offeringpage.jpg GRAPHIC 2477099
4 CPA AUDIT REPORT auditreport.pdf EX-99 383291
5 CERTIFICATE OF INCORPORATION certificateofincorporation.pdf EX-99 1950081
6 CORPORATE BYLAWS corporatebylaws.pdf EX-99 123173
7 PITCH DECK pitchdeck.pdf EX-99 4034031
8 ADDITIONAL INFORMATION otherfinancial.pdf EX-99 140687
9 IMAGE ATTACHMENTS HTML imageattachments.htm EX-99 244
  Complete submission text file 0001669191-20-000843.txt   12797796
Mailing Address 999 WEST 1500 SOUTH BUILDING 600 WOODS CROSS UT 84087
Business Address 999 WEST 1500 SOUTH, BUILDING 600 WOODS CROSS UT 84087 8014200285
Phoenix PharmaLabs Inc (Filer) CIK: 0001755778 (see all company filings)

EIN.: 731626743 | State of Incorp.: UT | Fiscal Year End: 1231
Type: C | Act: 33 | File No.: 020-27364 | Film No.: 201401258